tiprankstipranks
NexgenRx Inc (TSE:NXG)
:NXG
Canadian Market

NexgenRx (NXG) Income Statement

Compare
14 Followers

NexgenRx Income Statement

Last quarter (Q3 2024), NexgenRx's total revenue was $―, a decrease of ― from the same quarter last year. In Q3, NexgenRx's net income was $149.23K. See NexgenRx’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Dec 23Dec 22Dec 21Dec 20Dec 19
Total Revenue
$ ―$ ―$ ―$ ―$ ―
Gross Profit
$ 10.82M$ ―$ 9.81M$ 9.67M$ 8.37M
Operating Expenses
$ ―$ ―$ ―$ ―$ ―
Depreciation and Amortization
$ 1.31M$ 1.41M$ 1.33M$ 936.99K$ 832.75K
EBITDA
$ 1.15M$ ―$ 3.40M$ 2.96M$ 815.97K
Operating Income
$ -143.88K$ ―$ 2.20M$ 2.16M$ 93.52K
Other Income/Expenses
$ ―$ ―$ ―$ ―$ ―
Pretax Income
$ ―$ ―$ ―$ ―$ ―
Net Income
$ -331.97K$ ―$ 4.02M$ 2.12M$ -207.94K
Per Share Metrics
$ ―$ ―$ ―$ ―$ ―
Basic EPS
$ ―$ ―$ ―$ ―$ ―
Diluted EPS
$ ―$ ―$ ―$ ―$ ―
Weighted Average Shares Outstanding
Weighted Average Shares Outstanding (Diluted)
Currency in USD

NexgenRx Earnings and Revenue History

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis